AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Choosing between cash back and points for travel can impact your rewards. Explore which option suits your travel style!
27,012 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
In 2026, nuclear energy climbs back into the spotlight as AI-driven electricity demand surges. This article lays out ...
As market volatility persists in 2026, a tax-advantaged Roth approach could dramatically lift after-tax income from a...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
Public family disputes can ripple through a household’s finances. This feature explains the money side of a high-prof...
Rising housing costs strain households and the broader economy. Smart tax policy can lower those costs by acceleratin...
The Russell 2000 has climbed roughly 31% over the past year, signaling a shift toward small-cap leadership. Two stock...
A 68-year-old retiree donates appreciated stock to a charity after being influenced by mackenzie scott’s giving inspi...
A self-employed architect plans a four-bucket retirement strategy that shifts income across Roth, HSA, and pretax acc...
A sharp market pullback followed a bold political statement about the Iran deal. This guide breaks down what happened...
A retirement decision with life-long consequences, the timing of Social Security claims can quietly alter tens of tho...
As rates shift and inflation cools, retirees seek a retirement portfolio that pays steady income with less daily tink...